According to an industry report, blood gas monitoring systems market is expected to reach $4.9 billion by the year 2023.
The report, produced by ResearchAndMarkets.com, projected total sales to increase at a CAGR of 6.1%, growing from $3.6 billion in 2018 to an estimated $4.9 billion in 2023.
The report includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for POC and laboratory blood gas analyzers, arterial blood gas sampling kits, pulse oximeters, and capnography/end-tidal CO2 monitoring products for the US, the five major EU markets, Japan, and rest of world markets.
Pulse oximeters and POC blood gas analyzers combined accounted for more than 85% of the total market, with $3.1 billion. Five companies account for more than 80% of the total market: Medtronic, Masimo, Abbott, Radiometer, and Siemens.
More information is available on the company’s website.
Go To Source For Respiratory Therapy Coverage
RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the respiratory care industry.
Go To Source For Respiratory Therapy Coverage
RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the respiratory care industry. RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the respiratory care industry.